2nd Quarter - Report

ARENTFOX SCHIFF LLP for TRANSPARENCY RISING CORP.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices H.R. 7148 (Consolidated Appropriations Act, 2026), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices H.R. 6609 and H.R. 6610 (Pharmacists Fight Back Act), generally H.R. 5582 and S. 2355 (Patients Deserve Price Tags Act), generally

LobbyistCovered position, as disclosed
PHILIP ENGLISH —
KATHERINE KRAMER —
DANIEL SJOSTEDT —
BLAKE THELANDER —

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2355 (119th), H.R. 5582 (119th), H.R. 7148 (119th), H.R. 6610 (119th), H.R. 6609 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.